CLINICAL_TRIALS
trial_result
· 2022-07-19
Clinical Trial Update: Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke [Phase 2, Phase 3]
Summary
A clinical trial update indicates ongoing evaluation of tirofiban for preventing neurological deterioration in acute ischemic stroke across phase 2 and phase 3 …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Capital Medical University | Conditions: Acute Stroke | Phase 2, Phase 3 | Status: UNKNOWN